Revolution Medicines Overview
Revolution Medicines Target Price
Analysts' 12-month price predictions for RVMD.
Get informed when a big investor buys or sells
+ FollowShare Price
$189.24
Average Target Price
$185.27
2.1% downside
2.1% downside15 analysts in the last 4 months
High: $235 | Low: $151
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-02 | Wedbush | $181 | 4.4% downside |  |
| 2026-06-30 | Truist Financial | $210 |  11% upside | |
| 2026-06-29 | NeedhamAmi Fadia | $235 | 24.2% upside | |
| 2026-06-09 | UBSMichael Yee | $175 | 7.5% downside | |
| 2026-06-02 | RBC CapitalLeonid Timashev | $182 | 3.8% downside | |
| 2026-06-01 | H.C. Wainwright | $195 | 3% upside | |
| 2026-06-01 | Oppenheimer | $195 | 3% upside | |
| 2026-05-21 | BernsteinJeffrey Walch | $151 | 20.2% downside | |
| 2026-05-18 | Truist Financial | $179 | 5.4% downside | |
| 2026-05-07 | Guggenheim | $205 | 8.3% upside | |
| 2026-04-14 | Guggenheim | $175 | 7.5% downside | |
| 2026-04-14 | Evercore ISI | $200 | 5.7% upside | |
| 2026-04-14 | RBC Capital | $162 | 14.4% downside | |
| 2026-04-14 | H.C. WainwrightRobert Burns | $169 | 10.7% downside | |
| 2026-04-13 | Oppenheimer | $165 | 12.8% downside | |
| 2026-02-26 | Wells FargoEva Fortea Verdejo | $144 | 23.9% downside | |
| 2026-01-27 | OppenheimerJay Olson | $150 | 20.7% downside | |
| 2026-01-22 | UBS | $170 | 10.2% downside | |
| 2026-01-21 | RBC CapitalLeonid Timashev | $140 | 26% downside | |
| 2026-01-20 | Guggenheim | $160 | 15.5% downside | |
| 2026-01-13 | Goldman SachsAndrea Newkirk | $73 | 61.4% downside | |
| 2026-01-13 | Mizuho Securities | $143 | 24.4% downside | |
| 2026-01-09 | Wedbush | $147 | 22.3% downside | |
| 2025-11-03 | RBC CapitalLeonid Timashev | $77 | 59.3% downside | |
| 2025-10-17 | National BankAlex Stranahan | $80 | 57.7% downside | |
| 2025-10-17 | Raymond James | $76 | 59.8% downside | |
| 2025-10-15 | Stifel Nicolaus | $85 | 55.1% downside | |
| 2025-09-05 | Truist Financial | $99 | 47.7% downside | |
| 2025-08-19 | Piper SandlerKelsey Goodwin | $75 | 60.4% downside | |
| 2025-05-14 | H.C. WainwrightRobert Burns | $72 | 62% downside | |
| 2025-04-01 | Stifel NicolausBenjamin Burnett | $64 | 66.2% downside | |
| 2025-01-08 | UBSEliana Merle | $71 | 62.5% downside | |
| 2024-11-07 | Piper SandlerJoseph Catanzaro | $70 | 63% downside | |
| 2024-11-04 | H.C. WainwrightRaghuram Selvaraju | $62 | 67.2% downside | |
| 2024-10-28 | GuggenheimMichael Schmidt | $82 | 56.7% downside | |
| 2024-10-28 | OppenheimerJay Olson | $60 | 68.3% downside | |
| 2024-10-15 | OppenheimerJay Olson | $55 | 70.9% downside | |
| 2024-09-17 | Piper SandlerJoseph Catanzaro | $57 | 69.9% downside | |
| 2024-08-08 | NeedhamAmi Fadia | $61 | 67.8% downside | |
| 2024-07-15 | WedbushRobert Driscoll | $59 | 68.8% downside | |
| 2024-04-19 | Stifel NicolausBen Burnett | $43 | 77.3% downside | |
| 2024-04-12 | NeedhamAmi Fadia | $46 | 75.7% downside | |
| 2024-04-12 | OppenheimerJay Olson | $45 | 76.2% downside | |
| 2024-04-10 | Raymond JamesLaura Prendergast | $48 | 74.6% downside | |
| 2023-11-16 | Raymond JamesDane Leone | $30 | 84.1% downside | |
| 2022-12-14 | Needham | $31 | 83.6% downside | |